Department of Radiology and Imaging Sciences, Indiana University School of Medicine, R2 E124, 950 W. Walnut St., Indianapolis, IN, 46202, USA.
Brain Imaging Behav. 2013 Sep;7(3):326-34. doi: 10.1007/s11682-013-9233-4.
Studies have reported lower striatal D₂/D₃ receptor availability in both alcoholics and cigarette smokers relative to healthy controls. These substances are commonly co-abused, yet the relationship between comorbid alcohol/tobacco abuse and striatal D₂/D₃ receptor availability has not been examined. We sought to determine the degree to which dual abuse of alcohol and tobacco is associated with lower D₂/D₃ receptor availability. Eighty-one subjects (34 nontreatment-seeking alcoholic smokers [NTS-S], 21 social-drinking smokers [SD-S], and 26 social-drinking non-smokers [SD-NS]) received baseline [(11)C]raclopride scans. D₂/D₃ binding potential (BPND ≡ Bavail/KD) was estimated for ten anatomically defined striatal regions of interest (ROIs). Significant group effects were detected in bilateral pre-commissural dorsal putamen, bilateral pre-commissural dorsal caudate; and bilateral post-commissural dorsal putamen. Post-hoc testing revealed that, regardless of drinking status, smokers had lower D₂/D₃ receptor availability than non-smoking controls. Chronic tobacco smokers have lower striatal D₂/D₃ receptor availability than non-smokers, independent of alcohol use. Additional studies are needed to identify the mechanisms by which chronic tobacco smoking is associated with striatal dopamine receptor availability.
研究报告称,与健康对照组相比,酗酒者和烟民的纹状体 D₂/D₃ 受体可用性均较低。这些物质通常是同时滥用的,但尚未研究共病性酒精/烟草滥用与纹状体 D₂/D₃ 受体可用性之间的关系。我们试图确定双重滥用酒精和烟草与较低的 D₂/D₃ 受体可用性之间的关联程度。81 名受试者(34 名未接受治疗的酗酒吸烟者[NTS-S],21 名社交饮酒吸烟者[SD-S]和 26 名社交饮酒不吸烟者[SD-NS])接受了基线 [(11)C]raclopride 扫描。在十个解剖定义的纹状体感兴趣区(ROI)中估计了 D₂/D₃ 结合潜能(BPND ≡ Bavail/KD)。在双侧前连合背侧纹状体、双侧前连合背侧尾状核和双侧后连合背侧纹状体中检测到显著的组间效应。事后检验显示,无论饮酒状况如何,吸烟者的 D₂/D₃ 受体可用性均低于不吸烟的对照组。慢性吸烟与非吸烟者相比,纹状体 D₂/D₃ 受体的可用性较低,与酒精使用无关。需要进一步的研究来确定慢性吸烟与纹状体多巴胺受体可用性之间的关联机制。